ImmuCell Corporation
ICCC
$9.67
-$0.10-1.02%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1,939.44% | -127.83% | -65.31% | 181.19% | 173.34% |
| Total Depreciation and Amortization | 4.01% | 1.63% | -1.15% | 0.33% | -0.19% |
| Total Amortization of Deferred Charges | -89.19% | 174.07% | 0.00% | 0.00% | 0.00% |
| Total Other Non-Cash Items | 3,163.93% | -545.19% | 8.90% | -40.87% | -19.45% |
| Change in Net Operating Assets | 87.04% | -514.93% | 169.05% | 53.10% | -86.00% |
| Cash from Operations | 140.80% | -173.84% | 1.76% | 50,867.74% | 99.52% |
| Capital Expenditure | 70.99% | -282.67% | 52.84% | -67.74% | -121.95% |
| Sale of Property, Plant, and Equipment | 163.16% | -93.49% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 71.74% | -370.21% | 61.74% | -67.74% | -121.95% |
| Total Debt Issued | -100.00% | -- | -- | -- | -- |
| Total Debt Repaid | 64.90% | -194.78% | -0.34% | -1.58% | -1.60% |
| Issuance of Common Stock | -- | -100.00% | 1,600.52% | -96.40% | -85.39% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 41.37% | 42.09% | -165.43% | 85.38% |
| Cash from Financing | -16.85% | -342.02% | 81.07% | -371.05% | -95.36% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 96.24% | -250.98% | 66.34% | 1,768.85% | -102.03% |